Back to 
AMERIPRISE FINANCIAL INC
AMERIPRISE FINANCIAL INCPRPRAX
Showing 0 of 3 quarters
Position history for AMERIPRISE FINANCIAL INC's holdings in PRAXIS PRECISION MEDICINES I
No. Ameriprise Financial exited its PRAX (Praxis Precision Medicines) position in Q1 2023. Its Q4 2022 13F listed 54,698 shares worth $130,000. Ameriprise Financial first reported PRAX in Q3 2022 and held it in 2 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.